Financhill
Buy
57

TXRH Quote, Financials, Valuation and Earnings

Last price:
$167.15
Seasonality move :
6.13%
Day range:
$171.43 - $174.10
52-week range:
$146.75 - $206.04
Dividend yield:
1.42%
P/E ratio:
26.58x
P/S ratio:
2.14x
P/B ratio:
8.41x
Volume:
1M
Avg. volume:
1.4M
1-year change:
12.93%
Market cap:
$11.4B
Revenue:
$5.4B
EPS (TTM):
$6.47

Analysts' Opinion

  • Consensus Rating
    Texas Roadhouse has received a consensus rating of Hold. The company's average rating is a Hold based on 11 Buy ratings, 17 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $191.62, Texas Roadhouse has an estimated upside of 11.44% from its current price of $171.95.
  • Price Target Downside
    According to analysts, the lowest downside price target is $139.78 representing 100% downside risk from its current price of $171.95.

Fair Value

  • According to the consensus of 28 analysts, Texas Roadhouse has 11.44% upside to fair value with a price target of $191.62 per share.

TXRH vs. S&P 500

  • Over the past 5 trading days, Texas Roadhouse has underperformed the S&P 500 by -4.87% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Texas Roadhouse does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Texas Roadhouse has grown year-over-year revenues for 16 quarters straight. In the most recent quarter Texas Roadhouse reported revenues of $1.4B.

Earnings Growth

  • Texas Roadhouse has grown year-over-year earnings for 10 quarters straight. In the most recent quarter Texas Roadhouse reported earnings per share of $1.73.
Enterprise value:
11.2B
EV / Invested capital:
8.15x
Price / LTM sales:
2.14x
EV / EBIT:
21.37x
EV / Revenue:
2.08x
PEG ratio (5yr expected):
0.62x
EV / Free cash flow:
28.04x
Price / Operating cash flow:
28.86x
Enterprise value / EBITDA:
15.95x
Gross Profit (TTM):
$947.3M
Return On Assets:
14.86%
Net Income Margin (TTM):
8.07%
Return On Equity:
34.11%
Return On Invested Capital:
34.11%
Operating Margin:
9.64%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Income Statement
Revenue $4B $4.6B $5.4B $1.2B $1.4B
Gross Profit $653.6M $735.1M $947.3M $183.7M $251.8M
Operating Income $327.1M $359.9M $523.9M $83.9M $138.6M
EBITDA $464.2M $513.1M $702.1M $124.4M $187.9M
Diluted EPS $3.97 $4.53 $6.47 $1.08 $1.73
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Balance Sheet
Current Assets $510.7M $563.5M $396.8M $356.5M $516.6M
Total Assets $2.3B $2.5B $2.5B $2.8B $3.2B
Current Liabilities $506.3M $602.1M $652M $745.4M $828.1M
Total Liabilities $1.4B $1.4B $1.5B $1.6B $1.8B
Total Equity $943.1M $1.1B $1B $1.2B $1.4B
Total Debt $240M $100M $50M -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Cash Flow Statement
Cash Flow Operations $511.7M $565M $753.6M $174.2M $237.5M
Cash From Investing -$263.7M -$367.2M -$336.9M -$93.6M -$99.7M
Cash From Financing -$409.8M -$267.4M -$275.7M -$45.7M -$81.8M
Free Cash Flow $265.6M $218M $399.3M $71.1M $129.7M
TXRH
Sector
Market Cap
$11.4B
$413.9M
Price % of 52-Week High
83.46%
70.13%
Dividend Yield
1.42%
0%
Shareholder Yield
2.16%
3.83%
1-Year Price Total Return
12.93%
-14.97%
Beta (5-Year)
1.000
0.943
Dividend yield:
1.42%
Annualized payout:
$2.44
Payout ratio:
37.56%
Growth streak:
4 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Sell
Level $176.11
200-day SMA
Sell
Level $177.34
Bollinger Bands (100)
Sell
Level 175.79 - 193.49
Chaikin Money Flow
Buy
Level 76.1M
20-day SMA
Sell
Level $176.16
Relative Strength Index (RSI14)
Sell
Level 43.13
ADX Line
Sell
Level 19.43
Williams %R
Neutral
Level -75.2865
50-day SMA
Sell
Level $178.16
MACD (12, 26)
Sell
Level -1.29
25-day Aroon Oscillator
Sell
Level -24
On Balance Volume
Neutral
Level 110.7M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (6.6647)
Buy
CA Score (Annual)
Level (0.6434)
--
Beneish M-Score (Annual)
Level (--)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-0.3325)
Buy
Piotroski F Score (Annual)
Level (9)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (9)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Texas Roadhouse Inc is a restaurant company operating predominately in the casual dining segment. The company manages its restaurant and franchising operations by concept and, as a result, has identified Texas Roadhouse, Bubba’s 33, Jaggers, and retail initiatives as separate operating segments. In addition, it has identified Texas Roadhouse and Bubba's 33 as reportable segments. Maximum revenue for the company is generated from the Texas Roahouse segment, which is a moderately priced, full-service, casual dining restaurant concept offering steaks, a selection of ribs, seafood, chicken, pork chops, pulled pork, vegetable plates, and an assortment of hamburgers, salads, and sandwiches.

Stock Forecast FAQ

In the current month, TXRH has received 11 Buy ratings 17 Hold ratings, and 0 Sell ratings. The TXRH average analyst price target in the past 3 months is $191.62.

  • Where Will Texas Roadhouse Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Texas Roadhouse share price will rise to $191.62 per share over the next 12 months.

  • What Do Analysts Say About Texas Roadhouse?

    Analysts are divided on their view about Texas Roadhouse share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Texas Roadhouse is a Sell and believe this share price will drop from its current level to $139.78.

  • What Is Texas Roadhouse's Price Target?

    The price target for Texas Roadhouse over the next 1-year time period is forecast to be $191.62 according to 28 Wall Street analysts, 11 of them rate the stock a Buy, 0 rate the stock a Sell, and 17 analysts rate the stock a Hold.

  • Is TXRH A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Texas Roadhouse is a Hold. 17 of 28 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of TXRH?

    You can purchase shares of Texas Roadhouse via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Texas Roadhouse shares.

  • What Is The Texas Roadhouse Share Price Today?

    Texas Roadhouse was last trading at $167.15 per share. This represents the most recent stock quote for Texas Roadhouse. Yesterday, Texas Roadhouse closed at $171.95 per share.

  • How To Buy Texas Roadhouse Stock Online?

    In order to purchase Texas Roadhouse stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is CyberArk The Next Big Cybersecurity Stock?
Is CyberArk The Next Big Cybersecurity Stock?

CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…

Is the Market Going to Go Lower?
Is the Market Going to Go Lower?

The last month has been extremely difficult for the stock…

2 Dividend Stocks to Buy in a Recession
2 Dividend Stocks to Buy in a Recession

While many economists and investors initially expected 2025 to be…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
52
RGC alert for Mar 18

Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.

Buy
63
EXOD alert for Mar 18

Exodus Movement [EXOD] is down 3.96% over the past day.

Sell
45
MNPR alert for Mar 18

Monopar Therapeutics [MNPR] is up 0.93% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock